JOSEPH FLASK: Open Payments
NPI 1881230811 · SOLON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 46 payments from 6 companies in 2025. Trend: 2023 $70 · 2024 $476 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $278 |
| Alkermes, Inc. | 10 | $243 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $163 |
| Almatica Pharma LLC | 5 | $84 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: INVEGA SUSTENNA, ARISTADA, CAPLYTA, LOREEV XR, AUSTEDO XR, LYBALVI, COBENFY.
Industry payments across OH — which companies pay providers there.
